$1,699.00 – $9,199.00
Indications for use of the drug Rozlytrek:
Monotherapy in adults and children aged 12 years and older with solid tumors expressing the neurotrophic receptor tyrosine kinase (NTRK) fusion gene:
in whom the disease is locally advanced, metastatic or where surgical resection is likely to result in severe complications and
who have not previously received an NTRK inhibitor
who lack satisfactory treatment options.
Monotherapy in adults with ROS1-positive advanced non-small cell lung cancer (NSCLC) who have not previously received ROS1 inhibitor therapy.
Active ingredient: Entrectinib
Prescription medicine
| Дозировка | 100 Gr 30 Tab, 200 Gr 90 Tab |
|---|
